Last Updated: 09/06/08

About the Branch Chief

Mr. Hall received his under-graduate pharmacy degree from the Massachusetts College of Pharmacy in 1975. He was awarded a Master of Science in Business Organizational Management from the University of LaVerne, California in 1991. In 1995, he completed an American Society of Hospital Pharmacy (ASHP) – accredited general pharmacy practice residency at the National Naval Medical Center, Bethesda, Maryland. More…

Pharmaceutical Management Branch (PMB)

The Pharmaceutical Management Branch (PMB) is charged with providing pharmaceutical support for clinical trials sponsored by the National Cancer Institute's (NCI) Cancer Therapy Evaluation Program (CTEP). This support includes:

• authorization and distribution of all CTEP-sponsored Investigational New Drug (IND) agents to eligible investigators
• provision of agent forecasting, agent acquisition, and inventory management of all IND agents distributed by CTEP for clinical trials
• provision of pharmaceutical information about CTEP IND agents
• coordination, authorization, and processing of all requests for Special Exception and Treatment Referral Center (TRC) IND agent use
• registration of all investigators participating in CTEP clinical trials and the maintenance of all registration records
• provision and management of high priority double blind, randomized clinical trials
• development and maintenance of a Treatment Referral Center for handling special CTEP clinical agent initiatives and referrals to high priority clinical trials
• distribution of agents to investigators for non-human (preclinical) use